Catamaran Corp (CTRX)

61.45
0.02 0.03
Prev Close 61.43
Open 61.44
Day Low/High 61.42 / 61.47
52 Wk Low/High 39.40 / 61.48
Volume 826.88K
Avg Volume 2.71M
Exchange
Shares Outstanding 208.01M
Market Cap 12.79B
EPS 1.53
Div & Yield N.A. (N.A)

Latest News

Crude Surge Marches Dow to Near Record Close

Crude Surge Marches Dow to Near Record Close

Wall Street was torn in two with the energy sector marching the Dow Jones Industrial Average higher, while health care and tech weighed on the Nasdaq.

Analysts' Actions -- Cirrus Logic, Ford, Kinder Morgan, PayPal and More

Analysts' Actions -- Cirrus Logic, Ford, Kinder Morgan, PayPal and More

Here are Thursday's top research calls, including upgrades for Cirrus Logic, PayPal and Kinder Morgan, and a downgrade for Ford.

Verizon Nixing Discounted Phones May Turn Into a Self-Inflicted Wound

Verizon Nixing Discounted Phones May Turn Into a Self-Inflicted Wound

Jim Cramer delves into Verizon ending its discounted phones and the impact to the carrier. He also touches on Warren Buffett's Precision Castparts buyout and what it means for Alcoa.

Jim Cramer Says Rethink Alcoa After Buffett Buys Precision Castparts

Jim Cramer Says Rethink Alcoa After Buffett Buys Precision Castparts

Jim Cramer answers viewers’ Twitter questions Monday from the floor of the New York Stock Exchange.

OptumRx, Catamaran Complete Combination

OptumRx, Catamaran Complete Combination

Optum announced the completion of its combination with Catamaran Corporation (NASDAQ: CTRX) (TSX: CCT).

Catamaran (CTRX) Is Today's Strong And Under The Radar Stock

Catamaran (CTRX) Is Today's Strong And Under The Radar Stock

Trade-Ideas LLC identified Catamaran (CTRX) as a strong and under the radar candidate

Computer Software & Services Stocks On The Rise With Help From 3 Stocks

Computer Software & Services Stocks On The Rise With Help From 3 Stocks

TheStreet highlights 3 stocks pushing the computer software & services industry higher today.

New Lifetime High Reached: Catamaran (CTRX)

New Lifetime High Reached: Catamaran (CTRX)

Trade-Ideas LLC identified Catamaran (CTRX) as a new lifetime high candidate

Don't Miss Today's Strong And Under The Radar Stock: Catamaran (CTRX)

Don't Miss Today's Strong And Under The Radar Stock: Catamaran (CTRX)

Trade-Ideas LLC identified Catamaran (CTRX) as a strong and under the radar candidate

Express Scripts Keeps Getting Better

Will it get involved in health care sector's deal mania?

CVS Health Will Buy Pharmacy Benefits Manager Omnicare for $12.7B

CVS Health Will Buy Pharmacy Benefits Manager Omnicare for $12.7B

The deal will help CVS expand its ability to provide prescriptions to assisted-living and long-term-care facilities, serving the rapidly aging American senior patient population.

First-Quarter Deals Near $1 Trillion Mark Highest Value Since 2007

First-Quarter Deals Near $1 Trillion Mark Highest Value Since 2007

Mega deals from strategic players across a variety of industries pushed first-quarter deals to the highest value since 2007.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Catamaran Corporation And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Catamaran Corporation And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

Catamaran (CTRX) Stock Falls Today Following UnitedHealth Group Acquisition Announcement

Catamaran (CTRX) Stock Falls Today Following UnitedHealth Group Acquisition Announcement

Shares of Catamaran (CTRX) declined in afternoon trading Tuesday, one day after UnitedHealth Group announced its agreement to buy the Illinois pharmacy benefits management firm for $12.8 billion.

Big Pharma Merger Monday Deals Disregard Biotech Bubble Talks

Big Pharma Merger Monday Deals Disregard Biotech Bubble Talks

Large pharmas continued the shopping spree, paying no attention to whispers of a biotech bubble.

Jim Cramer's 'Mad Money' Recap: Good Headlines Make All the Difference

Jim Cramer's 'Mad Money' Recap: Good Headlines Make All the Difference

It's nice to see the flow of money has reversed from last week's relentless selloff, Cramer says.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Catamaran Corporation And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Catamaran Corporation And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

Market News: Auspex Pharmaceuticals, Catamaran, Horizon Pharma

Market News: Auspex Pharmaceuticals, Catamaran, Horizon Pharma

The stock markets in the United States rallied today driven by optimism among investors that central banks will support the global economic growth. The markets also benefitted from reports on corporat...

CATAMARAN CORP. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To OptumRX

CATAMARAN CORP. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To OptumRX

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Catamaran Corp.

Stock Markets Soar on Trifecta of Good News

Stock Markets Soar on Trifecta of Good News

Stocks recapture positive territory for the year on a spate of pharma deals, as well as positive news from the Fed and China.

Energy Sector Leads Stock Markets Higher as Rally Rolls On

Energy Sector Leads Stock Markets Higher as Rally Rolls On

Stocks recapture positive territory for the year.

UnitedHealth Buying Pharmacy Benefit Manager Catamaran for $12.8 Billion

UnitedHealth Buying Pharmacy Benefit Manager Catamaran for $12.8 Billion

UnitedHealth will purchase outstanding Catamaran stock for $61.50 per share in cash. The deal is slated to close in the fourth quarter of this year.

Stocks Reclaim Year-to-Date Gains as China Talks Monetary Easing

Stocks Reclaim Year-to-Date Gains as China Talks Monetary Easing

Stocks begin the holiday-shortened week with a bounce following a deluge of big pharma M&A deals on Monday morning.

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Catamaran Corporation Of Commencement Of An Investigation Concerning The Fairness Of The Sale Of The Company To OptumRx --CTRX

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Catamaran Corporation Of Commencement Of An Investigation Concerning The Fairness Of The Sale Of The Company To OptumRx --CTRX

The following statement is being issued by Levi & Korsinsky, LLP: TO: ALL PERSONS OR ENTITIES WHO PURCHASED CATAMARAN CORPORATION STOCK PRIOR TO MARCH 30, 2015 .

Catamaran (CTRX) Stock Is Up Today on UnitedHealth Acquisition

Catamaran (CTRX) Stock Is Up Today on UnitedHealth Acquisition

Catamaran (CTRX) is gaining Monday following the announcement that it will be acquired by UnitedHealth (UNH).

CATAMARAN SHAREHOLDER ALERT: Johnson & Weaver, LLP Launches An Investigation Into The Proposed Sale Of Catamaran Corporation And Encourages Investors To Contact The Firm For Additional Information

CATAMARAN SHAREHOLDER ALERT: Johnson & Weaver, LLP Launches An Investigation Into The Proposed Sale Of Catamaran Corporation And Encourages Investors To Contact The Firm For Additional Information

Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Catamaran Corporation (NASDAQ: CTRX) breached their fiduciary duties in connection with the proposed sale...

Stock Futures Are Driving Higher Amid Big Pharma Mergers

Stock Futures Are Driving Higher Amid Big Pharma Mergers

Stock futures set up for a nice bounce to begin the week following a deluge of big pharma deals on Monday morning.

March 30 Premarket Briefing: 10 Things You Should Know

March 30 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are trending upward Monday as investors look to a short trading week with important economic data reports.